SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-18-010954
Filing Date
2018-10-10
Accepted
2018-10-10 19:11:40
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cbmg_s3.htm S-3 357309
2 EXHIBIT 5.1 cbmg_ex51.htm EX-5.1 10873
3 EXHIBIT 23.1 cbmg_ex231.htm EX-23.1 4897
4 IMAGE cbmg_s3000.jpg GRAPHIC 3182
5 IMAGE cbmg_s3001.jpg GRAPHIC 32193
6 IMAGE cbmg_s3002.jpg GRAPHIC 31030
7 IMAGE cbmg_s3003.jpg GRAPHIC 4562
  Complete submission text file 0001654954-18-010954.txt   472466
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227773 | Film No.: 181117009
SIC: 2836 Biological Products, (No Diagnostic Substances)